Litigation Details for Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. (D. Del. 2022)
✉ Email this page to a colleague
Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. (D. Del. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-03-03 |
| Court | District Court, D. Delaware | Date Terminated | 2022-07-18 |
| Cause | 35:1 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Parties | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | ||
| Patents | 10,105,323; 10,154,990; 6,762,180; 7,119,093; 9,907,756 | ||
| Attorneys | Megan E. O'Connor; Peter L. Giunta | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-03-14 | 12 | Redacted Document | U.S. Patent No. 9,907,756 (the “’756 patent”) and U.S. Patent No. 10,105,323 (the “’323 patent”). …well as U.S. Patent Nos. 7,119,093 (the “’093 patent”), 6,762,180 (the “’180 patent”), and 10,154,990 (the…has five patents listed in the FDA’s Orange Book as covering Ofev: the ’756 and ’323 patents as well …(the “’990 patent”). See Exhibit A, Orange Book Patent and Exclusivity Information for Ofev. Under the…was required to submit patent certifications to each of the Orange Book patents listed for Ofev. | External link to document |
| 2022-07-18 | 23 | Judgment - Consent | U.S. Patent No. 9,907,756 (“the ’756 patent”) and U.S. Patent No. 10,105,323 (“the ’323 patent”); …States or with respect to any patents other than the ’756 patent and ’323 patent. 9. The Complaint… equivalents, of any claim of the ’756 patent and ’323 patent. 3. The Parties agree that…on Cipla’s non-infringement of the’756 patent and ’323 patent. 4. Based on a review of the…will not infringe any claim of the ’756 patent or ’323 patent. Final Judgment of non-infringement is therefore | External link to document |
| 2022-03-03 | 6 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756 B2 ;10,105,323 B2. (mal) (…2022 18 July 2022 1:22-cv-00300 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
